NCT06265441

Comparison of Pain Relief Post Knee Arthroscopy Using IPACK + Adductor Canal Block vs. Adductor Canal Block Alone

Comparison of IPACK Block With Adductor Canal Block vs Adductor Canal Block Alone for Post Operative Analgesia Following Arthroscopic Knee Surgeries
Ain Shams University·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Postoperative Pain
Drug/Device/Intervention
Group A will receive adductor canal block after spinal anesthesia under a high-frequency ultrasound guidance in which the adductor canal is identified and 20 ml of 0.25% bupivacaine will be injected
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Ain Shams University
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Oct 01, 2024
Enrollment
40 participants
Primary outcome

Assessment of pain using the visual analogue scale (VAS) upon first ambulation after 8 hours from the completion of the surgical procedure and skin closure.

Summary

In this study, the invistigators aim to compare postoperative analgesia effectiveness between
 combined interspace between the popliteal artery and posterior capsule of the knee block
 (IPACK) and Adductor canal block vs. Adductor canal block alone after Arthroscopic knee
 surgeries focusing on VAS score assessment at 8 hours postoperative.

ICD-10 classifications
Acute painPostoperative intestinal obstructionPain, unspecifiedDuring surgical operationDuring surgical operation
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06265441
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06265441 through Pure Global AI's free database. This phase not specified trial is sponsored by Ain Shams University and is currently Not yet recruiting. The study focuses on Postoperative Pain. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.